文献速递胸部介入CT

电视辅助胸腔镜手术后残留磨玻璃结节样肺癌的微波消融:一项回顾性大样本多中心研究

Microwave ablation for residual ground-glass nodule-like lung cancer after video-assisted thoracoscopic surgery: a retrospective, large-sample, multicenter study.
PubMed 文献 · Radiol Med · 2025-10-04

该回顾性大样本多中心研究纳入216例电视辅助胸腔镜手术(VATS)后残留磨玻璃结节(GGN)样肺癌患者(235次CT引导经皮微波消融,MWA),技术成功率100%,主要并发症包括气胸12.3%、胸腔积液5.5%、肺部感染2.6%等,无MWA相关死亡,消融后1-3个月肺功能与基线无显著差异,中位随访58.5个月,1、3、5年总生存率分别为100%、99.1%、96.3%。

要点

  • VATS术后残留GGN样肺癌行CT引导经皮MWA技术成功率100%,无操作相关死亡。
  • 主要并发症为气胸12.3%(29/235)、胸腔积液5.5%(13/235)、肺部感染2.6%(6/235)。
  • MWA后1-3个月肺功能与基线无显著差异,1、3、5年OS分别为100%、99.1%、96.3%。

核心结论

  • CT引导经皮MWA对VATS术后残留GGN样肺癌患者是一种安全、有效且可能根治的方法。

研究设计与样本

  • 回顾性、大样本、多中心研究,纳入216例患者共216个残留GGN样肺癌,接受235次CT引导经皮MWA,均为VATS(R0)切除的I-IIA期肺腺癌,时间范围为2016年7月至2023年12月;主要终点为技术成功、并发症及MWA后肺功能变化,次要终点为局部无进展生存(LPFS)和总生存(OS)。

诊断标准与关键数值

  • 技术成功率为100%。
  • 主要并发症:气胸12.3%(29/235)、胸腔积液5.5%(13/235)、肺部感染2.6%(6/235)、液气胸1.3%(3/235)、胸腔内出血0.4%(1/235)、支气管胸膜瘘0.4%(1/235)。
  • MWA后1-3个月肺功能与基线无显著差异。
  • 中位随访58.5个月,1、3、5年OS率分别为100%、99.1%、96.3%。
  • MWA后中位随访33.8个月,1、2、3年LPFS率分别为100%、97.7%、96.3%。

临床应用与阅片要点

  • 对于VATS术后残留GGN样肺癌且不适合再手术的患者,CT引导经皮MWA技术成功率高,可作为临床处理选择。
  • 阅片及报告需关注MWA后气胸、胸腔积液、肺部感染、液气胸、胸腔内出血及支气管胸膜瘘等并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: The management of residual or new ground-glass nodule (GGN)-like lung cancer after video-assisted thoracoscopic surgery (VATS) is challenging for patients who are not suitable for reoperation. This retrospective, large-sample, multicenter study aimed to evaluate the feasibility, safety, and preliminary efficacy of microwave ablation (MWA) for residual GGN-like lung cancer after VATS in early-stage lung cancer.

METHODS: A total of 216 patients with 216 residual GGN-like lung cancers who underwent 235 procedures of CT-guided percutaneous MWA after VATS (R0) of stage I-IIA lung adenocarcinoma from July 2016 to December 2023 were included in the study. The primary endpoints were technical success, complications, and pulmonary function test (PFT) variations after the MWA procedure. The secondary endpoints were local progression-free survival (LPFS) and overall survival (OS).

RESULTS: The rate of technical success was 100%. The major complications after MWA included pneumothorax (12.3%, 29/235), pleural effusion (5.5%, 13/235), pulmonary infection (2.6%, 6/235), hydropneumothorax (1.3%, 3/235), intrathoracic hemorrhage (0.4%, 1/235), and bronchopleural fistula (0.4%, 1/235). No MWA procedure-related death was observed. The PFT at 1-3 months after MWA was not significantly different from the baseline. The median follow-up duration was 58.5 months, and the 1-, 3- and 5-year OS rates were 100%, 99.1% and 96.3%, respectively. The median follow-up period after MWA was 33.8 months, and the 1-, 2- and 3-year LPFS rates were 100%, 97.7% and 96.3%, respectively.

CONCLUSIONS: CT-guided percutaneous MWA is a safe, effective, and potentially curative approach for patients with residual GGN-like lung cancer after VATS.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Hu Y, Li D, Ding M, et al. Microwave ablation for residual ground-glass nodule-like lung cancer after video-assisted thoracoscopic surgery: a retrospective, large-sample, multicenter study. Radiol Med. 2025. PMID: 41045356. doi:10.1007/s11547-025-02112-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。